| Net income/(loss) attributable to the Company |
54.08M |
| Net income attributable to noncontrolling interests |
3.01M |
| Net (income)/loss from discontinued operations |
-4.36M |
| Net income/(loss) from continuing operations |
52.73M |
| Depreciation and amortization |
17M |
| Net income attributable to noncontrolling interests |
-3.01M |
| Equity issued as compensation |
2.19M |
| Provision for loan losses |
-5.81M |
| Loans originated for sale |
-61.77M |
| Proceeds from sale of loans held for sale |
65.09M |
| Gain on the repurchase of debt |
| Decrease/(increase) in income tax receivable and deferred |
| Net decrease/(increase) in other operating activities |
-2.13M |
| Net cash provided by/(used in) operating activities of continuing operations |
68M |
| Net cash provided by/(used in) operating activities of discontinued operations |
4.36M |
| Net cash provided by/(used in) operating activities |
72.36M |
| Purchases |
-323.27M |
| Sales |
41.96M |
| Maturities, redemptions, and principal payments |
131.25M |
| Purchases |
0 |
| Maturities, sales, and principal payments |
16.91M |
| (Investments)/distributions in trusts, net |
-539K |
| (Purchase)/ redemption of Federal Home Loan Banks stock |
-903K |
| Net (increase)/ decrease in portfolio loans |
-156.69M |
| Proceeds from sale of OREO |
1.34M |
| Proceeds from sale and repayments of non-strategic loan portfolio |
| Capital expenditures, net of sale proceeds |
-7.1M |
| Cash received from dispositions/ (paid for acquisitions, including deferred acquisition obligations, net of cash acquired) |
| Net cash provided by/(used in) investing activities |
-288.7M |
| Net increase in deposits |
-122.41M |
| Net (decrease)/increase in securities sold under agreements to repurchase and other |
| Net (decrease)/increase in federal funds purchased |
125M |
| Net (decrease)/increase in short-term Federal Home Loan Bank borrowings |
95M |
| Advances of long-term Federal Home Loan Bank borrowings |
67.18M |
| Repayments of long-term Federal Home Loan Bank borrowings |
-100.82M |
| Repurchase of debt |
| Net proceeds from issuance/ (paid for repurchase) of Series C Preferred stock |
| Dividends paid to common stockholders |
-24.94M |
| Dividends paid to preferred stockholders |
-2.61M |
| Tax deficiency from certain stock compensation awards |
| Proceeds from stock option exercises |
789K |
| Proceeds from issuance of common stock, net |
841K |
| Other equity adjustments |
-350K |
| Net cash provided by/(used in) financing activities |
45.28M |
| Net increase/(decrease) in cash and cash equivalents |
-171.06M |
| Cash and cash equivalents at beginning of period |
238.69M |
| Cash and cash equivalents at end of period |
67.63M |
| Cash paid for interest |
20.49M |
| Cash paid for income taxes, net of (refunds received) |
27.55M |
| Change in unrealized gain/ (loss) on securities available for sale, net |
| Change in unrealized gain/ (loss) on cash flow hedges, net |
| Change in unrealized gain/ (loss) on other, net |
| Held to maturity investments transferred to available for sale or other investments at amortized cost |
| Loans transferred into other real estate owned from held for sale or portfolio |
1.94M |
| Loans transferred into/(out of) held for sale from/(to) portfolio |
| Equity issued for acquisitions, including deferred acquisition obligations |
| Equity receivable related to June 18, 2010 investment agreement with Carlyle |
